Advertisement Natus Medical acquires NeuroCom International - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Natus Medical acquires NeuroCom International

Natus Medical, a provider of screening, diagnostic & treatment solutions, has completed its acquisition of privately held NeuroCom International, a developer of computerized tools for the assessment and rehabilitation of balance and mobility disorders.

Natus has acquired all outstanding shares of NeuroCom capital stock for $18 million, exclusive of direct costs of the acquisition. Natus believes that the acquisition will be immediately accretive to earnings, excluding associated one-time charges.

The acquisition is said to add to Natus’s growth opportunities by broadening its product offerings in the company’s neurology business.

Jim Hawkins, president and CEO of Natus, said: “This acquisition expands our neurology footprint into the growing balance and mobility assessment market. We are very excited about the growth opportunities in this developing field and we believe NeuroCom products can become the standard of care in this emerging field.”